Queen Margaret University is a university, founded in 1875 and located in Edinburgh, Scotland. It is named after Saint Margaret, wife of King Malcolm III of Scotland.

During the past decade, Queen Margaret University Lab conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Margaret University Lab" #1 collaborator was "Barry Callebaut" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Queen Margaret University Lab" are "Body Weight" (1 trials) and "Insulin Resistance" (1 trials). Many other conditions were trialed in "Queen Margaret University Lab" in a lesser frequency.

Most popular intervention types in "Queen Margaret University Lab" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo Dark chocolate" (2 trials) and "Polyphenol-rich Dark chocolate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Queen Margaret University Lab" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Queen Margaret University Lab". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Queen Margaret University Lab, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Queen Margaret University Lab, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".